Antibiotic Eye Drops for Conjunctivitis
For bacterial conjunctivitis, use topical moxifloxacin 0.5% one drop three times daily for 5-7 days as first-line therapy, as it provides superior gram-positive coverage including activity against common pathogens and some MRSA strains. 1, 2
Treatment Algorithm by Etiology
Bacterial Conjunctivitis (Mild to Moderate)
First-Line Options:
Alternative Fluoroquinolones (if moxifloxacin unavailable):
- Gatifloxacin 0.5%: Day 1 every 2 hours while awake (up to 8 times), then Days 2-7 two to four times daily 1, 4
- Levofloxacin 0.5%: Demonstrated 89% microbial eradication vs. 80% with ofloxacin 5
- Ofloxacin 0.3%: Four times daily for 5-7 days (second-line, lower eradication rates) 1, 5
Second-Line Options (when fluoroquinolones unavailable or cost-prohibitive):
- Gentamicin, tetracycline, or polymyxin B/trimethoprim 1, 6
- Povidone-iodine 1.25% ophthalmic solution may be as effective as topical antibiotics 6
Severe Bacterial Conjunctivitis
Clinical Features: Copious purulent discharge, pain, marked inflammation 1
Management:
- Obtain conjunctival cultures and Gram staining BEFORE initiating treatment 1, 6
- Consider loading dose: One drop every 5-15 minutes, then hourly applications 3
- Suspect gonococcal or chlamydial infection if severe 1
Gonococcal Conjunctivitis (REQUIRES SYSTEMIC THERAPY)
Critical: Topical antibiotics alone are INSUFFICIENT 1, 6
Treatment:
- Adults: Ceftriaxone 250 mg IM single dose PLUS azithromycin 1 g oral single dose 1
- Neonates: Ceftriaxone 25-50 mg/kg IV or IM single dose 1
- Daily monitoring until resolution is mandatory 1
- Immediate ophthalmology referral required 1
Chlamydial Conjunctivitis (REQUIRES SYSTEMIC THERAPY)
Critical: Topical therapy alone is insufficient; >50% of infants have infection at other sites 1, 6
Treatment:
- Adults: Azithromycin 1 g oral single dose OR doxycycline 100 mg oral twice daily for 7 days 1
- Neonates: Erythromycin base or ethylsuccinate 50 mg/kg/day oral divided into 4 doses for 14 days 1
- Children ≥45 kg but <8 years: Azithromycin 1 g oral single dose 1
- Children ≥8 years: Azithromycin 1 g oral single dose OR doxycycline 100 mg oral twice daily for 7 days 1
Viral Conjunctivitis (NO ANTIBIOTICS)
Management:
- Supportive care ONLY: Refrigerated preservative-free artificial tears four times daily and cold compresses 1
- Avoid antibiotics - no benefit and promotes resistance 1, 7
- For HSV conjunctivitis: Topical ganciclovir 0.15% gel OR trifluridine 1% solution PLUS oral antivirals (acyclovir, valacyclovir, or famciclovir) 1
- Never use topical corticosteroids in HSV without antiviral coverage - potentiates infection 1
Allergic Conjunctivitis (NO ANTIBIOTICS)
Management:
- Second-generation topical antihistamines with mast-cell stabilizing properties as first-line 1
- Cold compresses, refrigerated artificial tears, sunglasses 1
- Avoid antibiotics - no benefit 1
Critical Red Flags Requiring Immediate Ophthalmology Referral
- Visual loss 1
- Moderate or severe pain 1
- Severe purulent discharge 1
- Corneal involvement (infiltrate, ulcer, opacity) 1
- Conjunctival scarring 1
- Lack of response after 3-4 days of appropriate therapy 1, 6
- History of HSV eye disease 1
- Immunocompromised state 1
- Neonatal conjunctivitis (requires systemic treatment) 1
Special Populations
Contact Lens Wearers:
- Higher risk for Pseudomonas infection - use fluoroquinolones 6
- Advise discontinuation of contact lens use during treatment 1
Pediatric Patients:
- Fluoroquinolones (moxifloxacin, levofloxacin, gatifloxacin, ciprofloxacin, besifloxacin) approved for children >12 months 1
Suspected MRSA:
- Consider compounded topical vancomycin if fluoroquinolones fail 1
- MRSA isolates generally resistant to fluoroquinolones and aminoglycosides but susceptible to vancomycin 1
Common Pitfalls to Avoid
- Using antibiotics for viral conjunctivitis - promotes resistance and provides no benefit 1, 7
- Using topical corticosteroids in HSV without antiviral coverage - potentiates infection 1
- Treating gonococcal or chlamydial conjunctivitis with topical antibiotics alone - systemic therapy is mandatory 1, 6
- Failing to consider sexual abuse in children with gonococcal or chlamydial conjunctivitis 1
- Ignoring local resistance patterns - fluoroquinolone resistance varies geographically 1, 3
- Not obtaining cultures in severe cases - delays appropriate therapy 1, 6